A drive-through point-of-care international normalized ratio (INR) testing model in a rural community during the pandemic promoted patient engagement and achieved maintenance of INR time in therapeutic range (TTR) above the benchmark for anticoagulation management, according to recent data published in the January 2022 issue of the American Journal of Health-System Pharmacy.
Maria G. Tanzi, PharmD